Cargando…
Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS:...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077022/ https://www.ncbi.nlm.nih.gov/pubmed/32178694 http://dx.doi.org/10.1186/s13014-020-1468-9 |
_version_ | 1783507343903817728 |
---|---|
author | Lin, Ting-Chun Lin, Chih-Yuan Li, Kai-Chiun Ji, Jin-Huei Liang, Ji-An Shiau, An-Cheng Liu, Liang-Chih Wang, Ti-Hao |
author_facet | Lin, Ting-Chun Lin, Chih-Yuan Li, Kai-Chiun Ji, Jin-Huei Liang, Ji-An Shiau, An-Cheng Liu, Liang-Chih Wang, Ti-Hao |
author_sort | Lin, Ting-Chun |
collection | PubMed |
description | BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS: A cohort of 99 node-negative left-sided breast cancer patients completed hypofractionated whole-breast irradiation with six-field IMRT for 42.56 Gy in 16 daily fractions from year 2016 to 2018 at a tertiary center were re-planned with an in-house-developed algorithm. The automated plan-generating C#-based program is developed in a Varian ESAPI research mode. The dose-volume histogram (DVH) and other dosimetric parameters of the automated and manual plans were directly compared. RESULTS: The average time for generating an autoplan was 5 to 6 min, while the manual planning time ranged from 1 to 1.5 h. There was only a small difference in both the gantry angles and the collimator angles between the autoplans and the manual plans (ranging from 2.2 to 5.3 degrees). Autoplans and manual plans performed similarly well in hotspot volume and PTV coverage, with the autoplans performing slightly better in the ipsilateral-lung-sparing dose parameters but were inferior in contralateral-breast-sparing. The autoplan dosimetric quality did not vary with different breast sizes, but for manual plans, there was worse ipsilateral-lung-sparing (V(4Gy)) in larger or medium-sized breasts than in smaller breasts. Autoplans were generally superior than manual plans in CI (1.24 ± 0.06 vs. 1.30 ± 0.09, p < 0.01) and MU (1010 ± 46 vs. 1205 ± 187, p < 0.01). CONCLUSIONS: Our study presents a well-designed standardized fully automated planning algorithm for optimized whole-breast radiotherapy treatment plan generation. A large cohort of 99 patients were re-planned and retrospectively analyzed. The automated plans demonstrated similar or even better dosimetric quality and efficacy in comparison with the manual plans. Our result suggested that the autoplanning algorithm has great clinical applicability potential. |
format | Online Article Text |
id | pubmed-7077022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70770222020-03-18 Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer Lin, Ting-Chun Lin, Chih-Yuan Li, Kai-Chiun Ji, Jin-Huei Liang, Ji-An Shiau, An-Cheng Liu, Liang-Chih Wang, Ti-Hao Radiat Oncol Research BACKGROUND: Hypofractionated whole-breast irradiation is a standard adjuvant therapy for early-stage breast cancer. This study evaluates the plan quality and efficacy of an in-house-developed automated radiotherapy treatment planning algorithm for hypofractionated whole-breast radiotherapy. METHODS: A cohort of 99 node-negative left-sided breast cancer patients completed hypofractionated whole-breast irradiation with six-field IMRT for 42.56 Gy in 16 daily fractions from year 2016 to 2018 at a tertiary center were re-planned with an in-house-developed algorithm. The automated plan-generating C#-based program is developed in a Varian ESAPI research mode. The dose-volume histogram (DVH) and other dosimetric parameters of the automated and manual plans were directly compared. RESULTS: The average time for generating an autoplan was 5 to 6 min, while the manual planning time ranged from 1 to 1.5 h. There was only a small difference in both the gantry angles and the collimator angles between the autoplans and the manual plans (ranging from 2.2 to 5.3 degrees). Autoplans and manual plans performed similarly well in hotspot volume and PTV coverage, with the autoplans performing slightly better in the ipsilateral-lung-sparing dose parameters but were inferior in contralateral-breast-sparing. The autoplan dosimetric quality did not vary with different breast sizes, but for manual plans, there was worse ipsilateral-lung-sparing (V(4Gy)) in larger or medium-sized breasts than in smaller breasts. Autoplans were generally superior than manual plans in CI (1.24 ± 0.06 vs. 1.30 ± 0.09, p < 0.01) and MU (1010 ± 46 vs. 1205 ± 187, p < 0.01). CONCLUSIONS: Our study presents a well-designed standardized fully automated planning algorithm for optimized whole-breast radiotherapy treatment plan generation. A large cohort of 99 patients were re-planned and retrospectively analyzed. The automated plans demonstrated similar or even better dosimetric quality and efficacy in comparison with the manual plans. Our result suggested that the autoplanning algorithm has great clinical applicability potential. BioMed Central 2020-03-17 /pmc/articles/PMC7077022/ /pubmed/32178694 http://dx.doi.org/10.1186/s13014-020-1468-9 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lin, Ting-Chun Lin, Chih-Yuan Li, Kai-Chiun Ji, Jin-Huei Liang, Ji-An Shiau, An-Cheng Liu, Liang-Chih Wang, Ti-Hao Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title | Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title_full | Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title_fullStr | Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title_full_unstemmed | Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title_short | Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer |
title_sort | automated hypofractionated imrt treatment planning for early-stage breast cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077022/ https://www.ncbi.nlm.nih.gov/pubmed/32178694 http://dx.doi.org/10.1186/s13014-020-1468-9 |
work_keys_str_mv | AT lintingchun automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT linchihyuan automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT likaichiun automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT jijinhuei automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT liangjian automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT shiauancheng automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT liuliangchih automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer AT wangtihao automatedhypofractionatedimrttreatmentplanningforearlystagebreastcancer |